Detalhe da pesquisa
1.
A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's.
Rheumatology (Oxford)
; 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291895
2.
A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS).
Rheumatology (Oxford)
; 62(9): 3133-3138, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36637209
3.
Expression of MHC class I dimers and ERAP1 in an ankylosing spondylitis patient cohort.
Immunology
; 133(3): 379-85, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21574996